Engstad
Pal-Kristian Engstad, Los Angeles, CA US
Patent application number | Description | Published |
---|---|---|
20100283783 | Environment Mapping - A system and method for environment mapping determines a computer-generated object's reflective appearance, based upon position and orientation of a camera with respect to the object's location. An embodiment of the present invention is implemented as a real-time environment mapping for polygon rendering, however, the scope of the invention covers other rendering schemes. According to one embodiment of the present invention, a vector processing unit (VPU) uses a modified reflection formula—r=e−(e·(n+e | 11-11-2010 |
Pal-Kristian Engstad, Tokyo JP
Patent application number | Description | Published |
---|---|---|
20090002380 | Graphics Processing Apparatus, Graphics Library Module And Graphics Processing Method - There is provided a graphics processing system that includes a main processing unit and a graphics processing unit (GPU). The main processing unit puts rendering commands generated using a graphics library in the queue of a command buffer in a main memory. In this process, the library function offered by the graphics library is converted into the rendering commands, without any rendering attributes retained in the library. The GPU reads and executes the rendering commands stacked in the command buffer, and generates rendering data in a frame buffer. | 01-01-2009 |
Rolf Engstad, Tromso NO
Patent application number | Description | Published |
---|---|---|
20110104208 | Enzyme Treatment of Glucans - β-(1-6)-Glucanese treatment of glucan from yeast cells, pure or feed grade, especially yeast from the family | 05-05-2011 |
20130296265 | Methods of Skin Treatment and Use of Water-Soluble Beta-(1,3) Glucans as Active Agents for Producing Therapeutic Skin Treatment Agents - A method of treating an ulcer comprising applying to the ulcer a preparation comprising a water-soluble β-(1,3) glucan with β-(1,6) linked side-chains, where the side-chains comprise β-(1,3) linkages or up to four consecutive β-(1,6) linkages a active ingredients. | 11-07-2013 |
20130309286 | Glucan Compositions - The present invention relates to a gel composition comprising a glucan and a gelling agent, said composition having a melting point (gel to sol) above 37° C., as well as to the uses of this composition in therapy, in particular in wound healing. | 11-21-2013 |
20130310338 | Glucans - The present invention relates to a glucan having a weight average molar mass of 15,000 to 50,000 g/mol on a single chain basis and a weight average molar mass in aqueous solution on an aggregate basis of 4 to 20×10 | 11-21-2013 |
20130315979 | Glucan Gels - The present invention relates to a glucan having a weight average molar mass of 15,000 to 50,000 g/mol on a single chain basis and a weight average molar mass in aqueous solution on an aggregate basis of 4 to 20×10 | 11-28-2013 |
Rolf Einar Engstad, Tromson NO
Patent application number | Description | Published |
---|---|---|
20110008476 | Methods of Treating or Preventing Inflammatory Diseases of the Intestinal Tract - The present invention relates to a glucan derived from yeast having a beta-(1, 3)-backbone with one or more beta-(1, 3)-side chains linked thereto for use in the treatment or prevention of inflammatory bowel disease and related diseases of abnormal bowel function in an animal, in particular to such uses employing a soluble glucan, e.g. from | 01-13-2011 |
Rolf Einar Engstad, Tromoso NO
Patent application number | Description | Published |
---|---|---|
20090004201 | Therapy-Enhancing Glucan - A therapeutic composition for treatment of cancer in a mammal is disclosed. The composition comprises an effective amount of a yeast beta-glucan composition which is suitable for oral administration and for absorption through the gastrointestinal tract of the mammal. The above therapeutic composition may further comprise antitumor antibodies or cancer vaccine composition, wherein the antitumor activities of the antitumor antibodies or the cancer vaccine composition are enhanced by the yeast glucan. | 01-01-2009 |
20090053221 | IMMUNE RESPONSE ENHANCING GLUCAN - This invention discloses a composition for enhancing the protective immunity in a subject, comprising an effective amount of a β-glucan and a vaccine, wherein the β-glucan enhances the immune response of the vaccine against cancer or infectious agents. The infectious agents can be viruses, fungi, bacteria or parasites. In one embodiment, the β-glucan is derived from yeast and comprises side chains attached to a β-(1,3) backbone. In another embodiment, the vaccine comprises an antibody and whole tumor cells. The invention also provides a method of enhancing protective immunity using said composition. | 02-26-2009 |
Rolf Einar Engstad, Tromosø NO
Patent application number | Description | Published |
---|---|---|
20130183295 | THERAPY-ENHANCING GLUCAN - This invention provides a method for introducing substances into cells comprising contacting a composition comprising orally administered beta-glucan with said cells. This invention also provides a method for introducing substances into a subject comprising administering to the subject an effective amount of the above compositions. The substance which could be delivered orally includes but is not limited to peptides, proteins, RNAs, DNAs, chemotherapeutic agents, biologically active agents, plasmids, and other small molecules and compounds. Finally, this invention provides a composition comprising orally administered beta-glucan capable of enhancing efficacy of IgM and different uses of the said composition. | 07-18-2013 |